Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From I-Hub (Nerverending)

In the words of the father of a possessed boy in the bible, "I believe, help my unbelief!"

A $3 share price would mean a market cap for PTSC of $1.23B. Currently, PTSC's market cap is $44.88M. Please provide the future circumstances that would have to take place and put them in the context of a resultant financial analysis that would show that a $3 per share price would be achievable.

Your beliefs seem to be based solely on the value of the MMP, so with the '336 now cleared of USPTO hassle, how do you see PTSC and it's current management and BOD managing this valuable asset so that it increases shareholder value 26-fold.

Obviously, you feel your beliefs in your view are well founded and grounded in probable future realities, so I would expect, and I'm sure all of us would appreciate, your analysis that supports this forecast. TIA.

Share
New Message
Please login to post a reply